How alpha-synuclein helps the brain's immune response
Determining the mechanism of alpha-synuclein dependent innate immune responses in the brain
Researchers are looking at how the brain protein alpha-synuclein helps nerve cells fight infection and control inflammation, which could matter for people with Parkinson's disease and brain injury.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11325689 on NIH RePORTER |
What this research studies
This project examines how alpha-synuclein, a protein linked to Parkinson's disease, supports innate immune signaling in the brain. The team uses human stem-cell–derived dopaminergic neurons with CRISPR-made deletions of the SNCA gene to compare cells with and without alpha-synuclein. They measure antiviral effects, type I interferon signaling, and expression of interferon-stimulated genes to see how neurons themselves respond to immune challenges independent of microglia. The work links basic lab models to conditions like neurodegeneration and brain trauma to inform future patient-centered approaches.
Who could benefit from this research
Good fit: People with Parkinson's disease, recent brain injury, or other neurodegenerative or neuroinflammatory conditions are most closely related to the biology being studied.
Not a fit: People without central nervous system disorders or whose conditions do not involve alpha-synuclein are unlikely to see direct benefits from this specific research.
Why it matters
Potential benefit: If successful, this work could point to new ways to protect neurons from infection and reduce harmful inflammation in Parkinson's disease and other CNS disorders.
How similar studies have performed: Prior laboratory studies have suggested alpha-synuclein affects neuronal antiviral responses, but translating these findings into treatments is still new and unproven.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Beckham, John David — Ut Southwestern Medical Center
- Study coordinator: Beckham, John David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.